Latest news about Family Care Hospitals
Family Care Hospitals
2.97
+0.12(+4.21%)
Company Performance:
View Company Insights1D+4.21%
1M-5.11%
6M-20.80%
1Y-32.50%
5Y-84.94%
More news about Family Care Hospitals
12May 26
Family Care Hospitals Reports FY26 Net Loss of ₹868.29 Lakhs; CS Resigns
Family Care Hospitals Limited reported audited standalone financial results for FY26, posting a net loss of ₹868.29 lakhs on revenue from operations of ₹20.97 lakhs. The board approved a postal ballot, appointed a scrutinizer and e-voting agency, and recorded the resignation of Company Secretary Mrs. Neetu Maurya effective May 02, 2026. Auditors highlighted a ransomware attack on January 30, 2026, and ₹38.03 crore in unutilised Discount Coupon Voucher inventory as key matters of emphasis.
02May 26
Family Care Hospitals Limited Announces Resignation of Company Secretary and Compliance Officer
Family Care Hospitals Limited has announced the resignation of Mrs. Neetu Maurya as Company Secretary and Compliance Officer effective May 02, 2026, due to personal reasons. The disclosure was made to BSE Limited under Regulation 30 of SEBI Listing Obligations Regulations. Mrs. Maurya submitted her resignation letter on May 01, 2026, and requested the Board to complete all necessary statutory filings.
22Apr 26
Family Care Hospitals Limited Announces Board Meeting on April 27, 2026 for Q4 FY26 Results
Family Care Hospitals Limited has scheduled a board meeting for April 27, 2026, to approve standalone audited financial results for Q4 and full year ended March 31, 2026. The company has implemented trading window restrictions for designated persons from April 1, 2026, continuing until 48 hours after results declaration. This announcement complies with SEBI Listing Regulations and maintains the company's adherence to insider trading prohibition guidelines.
06Apr 26
Family Care Hospitals Confirms Non-Applicability Under SEBI Large Corporate Category
Family Care Hospitals Limited has confirmed to BSE that it does not fall under SEBI's Large Corporate category as per the November 26, 2018 circular on debt securities fund raising. The confirmation was filed on April 6, 2026, by Company Secretary Neetu Maurya, ensuring regulatory compliance and transparency regarding the company's classification status under SEBI's framework for large entities.
06Apr 26
Family Care Hospitals Submits Q4 FY26 Dematerialization Compliance Certificate to BSE
Family Care Hospitals Limited submitted its Q4 FY26 compliance certificate to BSE under SEBI regulations, confirming proper dematerialization of 600 shares across two certificates during the quarter. The company's registrar Purva Sharegistry certified that all regulatory procedures were followed within prescribed timelines. The submission demonstrates ongoing compliance with securities regulations and transparent shareholder record maintenance.
21Feb 26
Family Care Hospitals Notifies BSE of Director Re-appointments for Second Terms
Family Care Hospitals Limited formally informed BSE Limited about the successful re-appointment of three key directors for their second terms following postal ballot approval on February 20, 2026. The appointments include Mrs. Archana Chirawawala and Mr. Sanjeev Seth as Independent Directors, and Mr. Suchit Raghunath Modshing as Whole Time Director, all effective February 28, 2026.
21Jan 26
Dealmoney Commodities Revises Disclosure for ₹180 Crore Warrant Acquisition in Family Care Hospitals
Dealmoney Commodities Private Limited has submitted a revised disclosure correcting the diluted share capital figure in its warrant acquisition of Family Care Hospitals Limited. The company acquired 1.80 crore warrants for ₹180 crores through preferential allotment, representing a 24.76% stake. The corrected disclosure shows Family Care Hospitals' diluted share capital at 72.69 crore equity shares.
20Jan 26
Family Care Hospitals Reports Q3 FY26 Results, Recommends Director Reappointments
Family Care Hospitals Limited reported Q3 FY26 results with revenue of ₹6.01 lakhs and net loss of ₹95.74 lakhs for the quarter ended December 31, 2025. The company's nine-month revenue declined significantly to ₹15.11 lakhs from ₹788.03 lakhs in the previous year. The Board recommended reappointment of three directors for second terms and approved a postal ballot process for shareholder approval. The company received ₹4.67 crores from share warrant allotments during the quarter.
26Dec 25
Family Care Hospitals Completes ₹18.67 Cr Warrant Allotment, Appoints New CFO
Family Care Hospitals successfully allotted 18,677,500 convertible warrants at ₹10 per warrant, raising ₹4.67 crores upfront from 6 investors with conversion timeline of 18 months. The company strengthened its leadership by appointing Rajesh Julal More as CFO, who brings comprehensive expertise in financial management, regulatory compliance, and emerging technologies including AI-driven reporting and ESG practices.
28Oct 25
Family Care Hospitals CFO Resigns, Company Reports Financial Challenges
Family Care Hospitals Limited (FCHL) announced the resignation of CFO Amit Satishchand Tyagi, effective October 28, 2025, citing personal reasons. The company reported a net loss of ₹460.72 lakhs for Q2 2025 and ₹530.24 lakhs for H1 2025. FCHL also paid a ₹35,10,000 penalty to SEBI and created a provision for contingent liabilities of ₹368 lakhs related to lease matters at its Mahim Division.
13Aug 25
Family Care Hospitals' Statutory Auditors S.M Gupta & Co Resign Over Fee Dispute
S.M Gupta & Co, statutory auditors of Family Care Hospitals Limited (Scrip Code: 516110), have resigned effective August 12, 2025, due to disagreement over professional fees. The auditors cited that the proposed fee reduction was not commensurate with the required work scope, professional diligence, and resources needed for regulatory compliance. Family Care Hospitals has acknowledged the resignation and is required to appoint new auditors to ensure regulatory compliance.
05Aug 25
Family Care Hospitals Approves Q1 Financial Results and Reconstitutes Board Committees
Family Care Hospitals Limited held a board meeting on August 5, 2025, approving unaudited Q1 financial results and reconstituting all board committees. Mr. Nitesh Singh, a Non-executive Independent Director, will chair the Audit, Nomination and Remuneration, Stakeholders Relationship, and Risk Management Committees. Ms. Lucy Massey and Mr. Dhananjay Parikh join as members. The company submitted necessary documentation to BSE Limited, including an Integrated Filing for Q1 FY2025-26.
Industry Peers
Dr. Lal Path Labs
Vijaya Diagnostic Centre
Metropolis Healthcare
Thyrocare Technologies
Nephrocare Health Services
Krsnaa Diagnostics
Suraksha Diagnostic
One Global Service Provider
Health X Platform
3B BlackBio DX
1,684.60
(+1.88%)
1,377.80
(+3.91%)
560.05
(+1.95%)
535.55
(+2.65%)
633.40
(-0.96%)
556.90
(+2.22%)
263.40
(+0.30%)
618.00
(+1.10%)
329.65
(+4.77%)
1,167.70
(+0.13%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
